Document Type

Report

Publication Date

2011

Abstract

To significantly expand women’s access to modern family planning and comprehensive abortion care services a provisional license was awarded to Marie Stopes International-Ghana by the Ghana Food and Drugs Board for the introduction and provision of the first medical abortion regimen (mifepristone and misoprostol) in Ghana. The Population Council conducted this study to document the introduction process; findings from the study will provide much needed evidence to inform policy decisionmaking and the scale-up phase. Overall the study has shown that medical abortion is a viable option for Ghanaian women--an overwhelming number of those who have benefitted from the procedure are content and will use or recommend it. The report recommends that products and service be made easily accessible and available to all women, especially the vulnerable, in order to stem the mortality rates associated with unsafe abortion.

DOI

doi.org/10.31899/rh2.1052

Language

English

Project

Reducing Maternal Morbidity and Mortality (R3M) in Ghana

Share

COinS